loading
Schlusskurs vom Vortag:
$2.91
Offen:
$2.98
24-Stunden-Volumen:
669
Relative Volume:
0.04
Marktkapitalisierung:
$9.21M
Einnahmen:
$556.00K
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-1.3972
EPS:
-2.14
Netto-Cashflow:
$-6.23M
1W Leistung:
-0.20%
1M Leistung:
+6.41%
6M Leistung:
-7.14%
1J Leistung:
+30.00%
1-Tages-Spanne:
Value
$2.8459
$2.98
1-Wochen-Bereich:
Value
$2.71
$3.22
52-Wochen-Spanne:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
Firmenname
Cyclerion Therapeutics Inc
Name
Telefon
617-621-7722
Name
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Name
Mitarbeiter
1
Name
Twitter
@Cyclerion
Name
Nächster Verdiensttermin
2024-12-15
Name
Neueste SEC-Einreichungen
Name
CYCN's Discussions on Twitter

Vergleichen Sie CYCN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
2.8459 9.21M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.44 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.43 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.08 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.75 28.51B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-10-20 Eingeleitet Truist Buy
2021-09-24 Eingeleitet Cantor Fitzgerald Overweight
2019-06-03 Eingeleitet Credit Suisse Neutral

Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten

pulisher
Jun 18, 2025

Cyclerion Therapeutics Gains Shareholder Support at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
May 31, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading 6.5% Higher – Time to Buy? - Defense World

May 31, 2025
pulisher
May 30, 2025

Regina Graul, Ph.D., Promoted to Chief Executive Officer - marketscreener.com

May 30, 2025
pulisher
May 09, 2025

Renaissance Technologies LLC Invests $34,000 in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) - Defense World

May 09, 2025
pulisher
May 08, 2025

Cyclerion partners with Guggenheim for $20M stock sale By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 07, 2025

Cyclerion partners with Guggenheim for $20M stock sale - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

Cyclerion Therapeutics Enters $20M Sales Agreement - TipRanks

May 07, 2025
pulisher
May 06, 2025

CYCN: Company Stock Sale Proceeds Exclude Firm's Benefit | CYCN Stock News - GuruFocus

May 06, 2025
pulisher
Apr 21, 2025

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Apr 21, 2025
pulisher
Mar 18, 2025

Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart

Mar 18, 2025
pulisher
Mar 13, 2025

Akebia Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Feb 16, 2025

Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL

Feb 16, 2025
pulisher
Feb 05, 2025

3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St

Feb 05, 2025
pulisher
Feb 05, 2025

Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register

Feb 05, 2025
pulisher
Feb 05, 2025

Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics announces mixed shelf offering - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

3 Penny Stocks to Watch Now, 2/4/25 - TipRanks

Feb 04, 2025
pulisher
Feb 03, 2025

A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Feb 03, 2025
pulisher
Feb 03, 2025

Analyzing CYCN’s current quarter earnings projections - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Cyclerion’s Stock Surge: A Buying Opportunity? - timothysykes.com

Feb 03, 2025
pulisher
Feb 01, 2025

Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn

Feb 01, 2025
pulisher
Jan 31, 2025

Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn

Jan 31, 2025
pulisher
Jan 31, 2025

Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com

Jan 31, 2025

Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.95
price up icon 1.40%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):